Bjrn Pasternak, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined whether use of a GLP1 receptor agonist is associated with an increased risk for thyroid cancer in a Scandinavian cohort study in Denmark, Norway, and Sweden from 2007 to 2021
Why They Succeed Where Diets Fail Traditional weight loss requires fighting constant hunger with willpower
R470-478
Inside the push to get weight loss treatment covered by Medicare
Hiddemann W, Buechner T, Andreeff M , Woermann B, Clarkson B
Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development